The Pharmaceutical Litigation Group in our law firm is an experienced team of trial lawyers that concentrate on the representation of plaintiffs in Tasigna lawsuits.
When the walls thicken, the station narrowed.
Tasigna has been linked by researchers into a kind of disease that leads to life-threatening plaque to build up inside the arteries.
Novartis is currently looking to expand the uses of Tasigna beyond therapy of CML to include Parkinson’s and Alzheimer’s diseases after researchers found it helped a few of patients with those diseases.
This requires the hardening and narrowing of arteries in the arms, legs, brain, and heart.
Tasigna gained more than $1.
The purpose of this report is to provide information to you so that you have a better understanding of your choices.
Blockage of an artery can result in gangrene or limb amputation.
We all know you have a lot to worry about already, so we keep our case intake process as simple as possible.
Severe side effects experienced by patients prescribed and using the drugs include non-curable and life-endangering conditions like atherosclerosis which can lead to: More common side effects of Tasigna include any or all the following: The side effects listed above are just a few of the frequent side effects related to Tasigna.
In March 2016, California resident Kristi Lauris registered the wrongful death Tasigna lawsuit against the drug’s manufacturer.
Research shows that Novartis was aware of these conditions since 2011.
According to the Justice Department, “Novartis incentivized and forced the pharmacies to emphasize benefits to patients while understating the drug’s serious, potentially life-threatening side effects.
Other than this, atherosclerosis may also result in other forms of ailments, such as:● Carotid Artery Disease● Chronic Kidney Disease● Peripheral Artery Disease● Coronary Heart Disease.
Tasigna Removed From 2018 Medication Formulary Lists.
To some degree, litigation is regarded as a cost of doing business and harming some patients along the way looks inevitable.
Filing a Virginia Tasigna lawsuit can help people recover the compensation they deserve, and also serves to maintain Novartis accountable for the protection of its pharmaceutical drugs .
In April 2013, the prescribing information for Tasigna was upgraded in Canada after health officials warned that cases of atherosclerosis had been reported worldwide between January 2005 and January 2013.
What is Tasigna?
A fibrofatty plaque develops, the presence of that narrows the arterial passages.
Nilotinib (Tasigna) is approved by the FDA as a first treatment for patients with newly-diagnosed chronic phase CML and when other drugs aren’t working.
The lack of proper blood flow which occurs as a consequence of Tasigna atherosclerosis is severe and irreversible, causes infections and tissue death, and might require one or more limb amputations.
Lawsuits allege that, though patients and doctors were warned in Canada, the maker failed to disclose risks that are known to doctors and patients.
Every case is different and must be judged on its own merits.
According to the complaint, the Decedent was diagnosed in September 2013 — with peripheral artery disease — a symptom of arteriosclerosis, with 90-100 % blockages in his legs.
Any person who had been prescribed Tasigna for chronic myeloid leukemia (or for another condition) may suffer from atherosclerosis, peripheral arterial disease, and corresponding Tasigna complications.
Studies have shown a link between the Tasigna and atherosclerosis.
There has been no recall for Tasigna, despite many studies linking Tasigna and warnings in Canada.
Tasigna lawyers representing cases nationally believe that men and the families of persons may be eligible for significant compensation through filing Tasigna atherosclerosis lawsuits against Novartis.
The competitive advertising was sometimes illegal and unethical.
Blockage may even lead to a stroke if the artery is a carotid artery.
” This suit participating in a kickback scheme as well as accused Novartis of illegal marketing practices.
In 2013, Health Canada issued a Safety Warning after patients on Tasigna were diagnosed with atherosclerosis between 2005 and 2013.
A rapidly growing number of cancer patients are submitting Tasigna lawsuits against Novartis from its popular cancer drug.
Tasigna Class Action Lawsuit.
May 2013According to the American Journal of Hematology, researchers describe intra – and extra-cranial atherosclerosis’ progression that led to a stroke in a patient with previously reported Tasigna-related peripheral vascular disease.
How a Tasigna Lawsuit Can Help.
Researchers from the Mayo Clinic and University of Nebraska publish a case study in the American Journal of Hematology describing the onset of atherosclerosis that led to a patient’s stroke.
Prepare your case and assert it in front of the legal audience that is proper.
7 billion in sales.
7 billion in global sales.
It specifically targets the tyronise kinase responsible.